Related Experiment Video
Updated: Mar 15, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Sjögren's syndrome: from pathogenesis to novel therapeutic targets
Francesca Barone1, Serena Colafrancesco2
1Centre for Translational Inflammation Research, Institute of Inflammation and Ageing, University of Birmingham, UK. f.barone@bham.ac.uk.
Abstract:
Primary Sjögren's syndrome (pSS) is a chronic inflammatory autoimmune disease, characterised by a chronic infiltration of exocrine glands, mainly salivary glands, with the histological features of focal lymphocytic sialoadenitis. Disease spectrum is broad and the occurrence of several extra-glandular manifestations, and in rare cases lymphoma development, is well known. A specific approved treatment for pSS is still lacking and the detection of novel therapeutic biologic target is ongoing. The identification of biological fingerprints seems essential in order to stratify patients both in clinical trials and in real life. Discovery of new components of the inflammatory response will be the key in the future for the identification of novel additional therapeutic options.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
The JAK-STAT Signaling Pathway
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Nephrotic Syndrome II : Assessment and Medical Management
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Nephrotic Syndrome III : Nursing Management

